GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Promimic AB (OSTO:PRO) » Definitions » Revenue per Share

Promimic AB (OSTO:PRO) Revenue per Share : kr2.20 (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Promimic AB Revenue per Share?

Promimic AB's revenue per share for the three months ended in Sep. 2024 was kr0.56. Promimic AB's revenue per share for the trailing twelve months (TTM) ended in Sep. 2024 was kr2.20.

During the past 12 months, the average Revenue Per Share Growth Rate of Promimic AB was 23.10% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 83.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Promimic AB's Revenue per Share or its related term are showing as below:

OSTO:PRO' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 43.9   Med: 63.45   Max: 83
Current: 83

During the past 5 years, Promimic AB's highest 3-Year average Revenue Per Share Growth Rate was 83.00% per year. The lowest was 43.90% per year. And the median was 63.45% per year.

OSTO:PRO's 3-Year Revenue Growth Rate is ranked better than
96.36% of 741 companies
in the Medical Devices & Instruments industry
Industry Median: 7 vs OSTO:PRO: 83.00

Promimic AB Revenue per Share Historical Data

The historical data trend for Promimic AB's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Promimic AB Revenue per Share Chart

Promimic AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Revenue per Share
0.33 0.32 0.46 0.98 1.96

Promimic AB Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.53 0.54 0.46 0.64 0.56

Competitive Comparison of Promimic AB's Revenue per Share

For the Medical Devices subindustry, Promimic AB's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Promimic AB's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Promimic AB's PS Ratio distribution charts can be found below:

* The bar in red indicates where Promimic AB's PS Ratio falls into.



Promimic AB Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Promimic AB's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Revenue Per Share (A: Dec. 2023 )=Revenue (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=37.07/18.892
=1.96

Promimic AB's Revenue Per Share for the quarter that ended in Sep. 2024 is calculated as

Revenue Per Share (Q: Sep. 2024 )=Revenue (Q: Sep. 2024 )/Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
=10.668/18.933
=0.56

Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr2.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Promimic AB  (OSTO:PRO) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Promimic AB Revenue per Share Related Terms

Thank you for viewing the detailed overview of Promimic AB's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Promimic AB Business Description

Traded in Other Exchanges
N/A
Address
care of AstraZeneca Research and Development Molndal, AZ BioVentureHub, Molndal, SWE, 431 83
Promimic AB is a biomaterial company producing a nano-thin surface for all implant materials for faster osseointegration.